Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply

Catalent is the main supplier of fill-finish work, which involves filling and packaging syringes and injection pens, for Novo Nordisk’s Wegovy. 

Previous post The Value Of A Second Language: How Much Would You Pay To Be Fluent?
Next post Charter’s stock gets another downgrade with weak numbers that are ‘difficult to explain’